generic letrozole — United Healthcare
Primary prevention of breast cancer in women at increased risk
Initial criteria
- age ≥ 35 years
- Member does not have a prior diagnosis of breast cancer OR ductal carcinoma in situ (DCIS)
- Member is at low risk for adverse medication effects
- Member is at increased risk for breast cancer
- One of the following: generic tamoxifen 20 mg once daily OR (Member is post-menopausal AND one of the following: generic raloxifene 60 mg once daily OR generic anastrozole OR generic letrozole OR generic exemestane AND member has had failure, contraindication, or adverse reaction to anastrozole or letrozole)
Approval duration
up to 60 months (minus any prior therapy received)